Person

Alan Lotvin

Formerly EVP&President-PharmacyServices, CVS Health

Current S&P 500 boards
0
Current roles
0
Open-market buys
$316K
Open-market sales
$19.1M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • CVS
    CVS Health
    EVP&President-PharmacyServices
    Jun 2018 – last filing Aug 2022

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Aug 4, 2022CVSSale22,541$104.00$2.3M
Aug 3, 2022CVSSale70,398$98.00$6.9M
Aug 3, 2022CVSSale50,501$98.00$4.9M
Feb 1, 2022CVSSale21,386$106.50$2.3M
Jun 28, 2021CVSSale2,781$83.67$233K
Jan 8, 2021CVSSale25,836$75.00$1.9M
Nov 13, 2020CVSSale7,138$70.00$500K
May 11, 2020CVSBuy5,000$63.14$316K

SEC reporting-owner ID (CIK) 1472795 · all filings on EDGAR